首页> 外国专利> Use of a digalactolipid antigen or an antibody directed against it prepare a reagent for diagnosing, or a vaccine or medicament for preventing or treating, an apicomplexan parasite infection

Use of a digalactolipid antigen or an antibody directed against it prepare a reagent for diagnosing, or a vaccine or medicament for preventing or treating, an apicomplexan parasite infection

机译：双半乳糖脂抗原或针对其的抗体的用途可制备用于诊断或预防或治疗apiplexplexan寄生虫感染的疫苗或药物

页面导航

摘要
著录项
相似文献

摘要

A digalactolipid antigen (I) or an antibody directed against (I) is used to prepare a reagent for diagnosing, or a vaccine or medicament for preventing or treating, an apicomplexan parasite infection in humans or animals. Independent claims are also included for: (1) detecting an apicomplexan parasite infection by contacting a biological sample with (I) or an antibody directed against (I) and detecting any antigen-antibody complexes formed; (2) pharmaceutical composition comprising an antibody directed against (I); (3) immunogenic composition or vaccine comprising (I); (4) antibody directed against (I). ACTIVITY : Protozoacide. MECHANISM OF ACTION : Vaccine.

机译：双半乳糖脂抗原（I）或针对（I）的抗体用于制备用于诊断人或动物的apiplexplexan寄生虫感染的诊断试剂或疫苗或药物。还包括以下独立权利要求：（1）通过使生物样品与（I）或针对（I）的抗体接触来检测apicomplexan寄生虫感染，并检测形成的任何抗原-抗体复合物; （2）药物组合物，其包含针对（I）的抗体; （3）包含（I）的免疫原性组合物或疫苗; （4）针对（I）的抗体。活动：原生动物。作用机理：疫苗。

著录项

公开/公告号FR2912218A1

专利类型
公开/公告日2008-08-08

原文格式PDF
申请/专利权人 COMMISSARIAT A LENERGIE ATOMIQUE ETABLISSEMENT PUBLIC A CARACTERE INDUSTRIEL ET COMMERCIAL;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.);
展开▼

申请/专利号FR20070000859
发明设计人 BOTTE CYRILLE;SAIDANI NADIA;BLOCK MARYSE;DUBREMETZ JEAN FRANCOIS;VIAL HENRI;CESBRON DELAUW MARIE FRANCE;MERCIER CORINNE;MARECHAL ERIC;
展开▼

申请日2007-02-07
分类号G01N33/569;A61K39/002;A61K39/395;A61P33/02;
国家 FR
入库时间 2022-08-21 19:47:05

相似文献

专利
外文文献
中文文献